Machine Learning Blood Test Identifies Potential Early Biomarkers for Parkinson's Disease
Researchers utilizing machine learning and plasma proteomics have identified a potential protein panel that may aid in the early detection and clinical assessment of Parkinson's disease.
Key points
- Study analyzed plasma samples from 391 participants using a two-stage design.
- Machine learning identified a five-protein panel including LAMP1, APOD, VIM, CTSF, and HEG1.
- Selected biomarkers were also linked to cognitive scales and non-motor symptoms.
A new study published in Nature Health Sciences describes how researchers from the First Affiliated Hospital of Zhengzhou University and other institutions used machine learning and plasma proteomics to discover potential protein biomarkers for Parkinson's disease. Reliable and minimally invasive diagnostic tools for the progressive neurodegenerative condition have historically been lacking. To address this, the investigative team analyzed blood plasma samples from 391 participants using a structured, two-stage design.
During the initial discovery phase, quantitative proteomics highlighted 121 differentially expressed proteins associated with cellular processes such as oxidative stress, autophagy, and vesicle trafficking. Through a machine learning feature selection strategy, the researchers developed a specific plasma protein panel containing LAMP1, APOD, VIM, CTSF, and HEG1. Subsequent validation in an independent cohort demonstrated that this panel could effectively distinguish Parkinson's patients from healthy controls, while a simplified subset showed moderate ability to differentiate the condition from multiple system atrophy with predominant parkinsonism.
What to know: The findings suggest that specific blood proteins may eventually serve as accessible diagnostic aids, though further clinical validation in larger populations is necessary before widespread implementation. Readers should always consult a qualified healthcare provider regarding personal medical decisions and concerns.
Source Nature Health Sciences — nature.com/articles/s41531-026-01606-2 ↗
Read next
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…